Early detection and molecular characterization of disease progression are persistent challenges in modern medicine. Although genomic and transcriptomic profiling of tissue lesions and precursors has ...

The omics era is in large part defined by a shift from the old target-of-interest days to an unbiased, discovery-first mindset: from a few genes to the whole genome, from a couple of proteins to the ...